Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
Launched by PFIZER · Aug 28, 2008
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female adults aged 65 years or older on the day of vaccination and able to fulfill study requirements.
- Exclusion Criteria:
- • Previous vaccination with any licensed or experimental pneumococcal vaccine
- • Residence in a nursing home, long-term care facility, or similar facility
- • Known hypersensitivity to vaccination
- • Immune deficiency or suppression
About Pfizer
Pfizer Inc. is a global leader in biopharmaceutical innovation, dedicated to discovering, developing, and delivering advanced therapies that enhance patient outcomes across a wide range of medical conditions. With a rich history of scientific research and a commitment to quality, Pfizer focuses on areas such as oncology, immunology, cardiology, and rare diseases. The company leverages cutting-edge technology and collaborates with healthcare professionals, regulatory bodies, and academic institutions to conduct rigorous clinical trials that ensure the safety and efficacy of its products. Pfizer's mission is to bring breakthroughs that change patients' lives, exemplifying its commitment to health and wellness worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Blaricum, , Netherlands
Enschede, , Netherlands
Arnhem, , Netherlands
Alkmaar, , Netherlands
Nieuwegein, , Netherlands
Almelo, , Netherlands
Assen, , Netherlands
Deventer, , Netherlands
Amstelveen, , Netherlands
Nijmegen, , Netherlands
Kampen, , Netherlands
Zwolle, , Netherlands
Tilburg, Noord Brabant, Netherlands
Abbekerk, , Netherlands
Almere, , Netherlands
Alphen Aan De Rijn, , Netherlands
Amersfoort, , Netherlands
Amsterdam, , Netherlands
Apeldoorn, , Netherlands
Baarle Nassau, , Netherlands
Baarn, , Netherlands
Bedum, , Netherlands
Bennebroek, , Netherlands
Bergen Op Zoom, , Netherlands
Berkel Enschot, , Netherlands
Berkhout, , Netherlands
Bilthoven, , Netherlands
Breda, , Netherlands
Brunssum, , Netherlands
Dongen, , Netherlands
Eelde, , Netherlands
Eindhoven, , Netherlands
Emmen, , Netherlands
Epe, , Netherlands
Ettenleur, , Netherlands
Fijnaart, , Netherlands
Geldrop, , Netherlands
Goirle, , Netherlands
Gouda, , Netherlands
Groningen, , Netherlands
Grootebroek, , Netherlands
Haarlem, , Netherlands
Haren, , Netherlands
Harmelen, , Netherlands
Heerhugowaard, , Netherlands
Heerlen, , Netherlands
Heiloo, , Netherlands
Helmond, , Netherlands
Hengelo, , Netherlands
Hilvarenbeek, , Netherlands
Hilversum, , Netherlands
Hoofddorp, , Netherlands
Hoogezand, , Netherlands
Hoorn, , Netherlands
Houten, , Netherlands
Katwijk, , Netherlands
Kerkrade, , Netherlands
Leek, , Netherlands
Leeuwarden, , Netherlands
Leiden, , Netherlands
Leiderdorp, , Netherlands
Maarssen, , Netherlands
Maastricht, , Netherlands
Medemblik, , Netherlands
Noordwijk, , Netherlands
Oldenzaal, , Netherlands
Oosterhout, , Netherlands
Peize, , Netherlands
Rheden, , Netherlands
Riel, , Netherlands
Rijsbergen, , Netherlands
Rijssen, , Netherlands
Roden, , Netherlands
Roermond, , Netherlands
Roosendaal, , Netherlands
Schoorl, , Netherlands
Simpelveld, , Netherlands
Sittard, , Netherlands
Sleen, , Netherlands
Soest, , Netherlands
Son, , Netherlands
Spaubeek, , Netherlands
Steenbergen, , Netherlands
Tiel, , Netherlands
Uithoorn, , Netherlands
Urmond, , Netherlands
Utrecht, , Netherlands
Veldhoven, , Netherlands
Velp, , Netherlands
Venlo, , Netherlands
Waalwijk, , Netherlands
Warmenhuizen, , Netherlands
Weert, , Netherlands
Woerden, , Netherlands
Zeist, , Netherlands
Zevenaar, , Netherlands
Zutphen, , Netherlands
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials